<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="4178">
  <stage>Registered</stage>
  <submitdate>9/09/2005</submitdate>
  <approvaldate>9/09/2005</approvaldate>
  <nctid>NCT01997931</nctid>
  <trial_identification>
    <studytitle>The Impact of Bispectral Index Monitoring on Sedation Administration in Mechanically Ventilated Patients</studytitle>
    <scientifictitle>The Impact of Bispectral Index Monitoring on Sedation Administration in Mechanically Ventilated Patients</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>111/04</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Intensive Care</healthcondition>
    <healthcondition>Mechanically Ventilated Patients</healthcondition>
    <healthcondition>Sedated Patients</healthcondition>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - Bispectral Index Sedation monitor

Treatment: devices: Bispectral Index Sedation monitor


</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Optimised sedation management for patients through the use of BIS monitoring.</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Reduction in mechanical ventilation time.</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Reduced length of stay in the intensive care unit.</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Intubated and ventilated for at least 24 hours

          -  Sedated on morphine and midazelam infusions</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Intracranial injury

          -  Status epilepticus

          -  Facial Burns</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/09/2004</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/07/2005</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>The Alfred Hospital - Melbourne</hospital>
    <postcode>3004 - Melbourne</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Bayside Health</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>This prospective randomised controlled trial was designed to assess the effectiveness of the
      Bispectral Index Sedation (BIS) monitor in supporting clinical, sedation management decisions
      in mechanically ventilated ICU patients.

      The primary hypothesis for the study is that patients with Bispectral Index Sedation (BIS)
      monitoring will receive less sedation then those receiving standard sedation management.

      The secondary hypotheses are:

        1. Patients with BIS have fewer ventilation days than those receiving standard sedation
           management.

        2. Level of sedation administered will differ according to the critical care experience and
           qualification of the nurse.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT01997931</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Cindy A Weatherburn</name>
      <address>The Alfred</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>